Palivizumab prophylaxis of RSV infections in Bosnia and Herzegovina

Palivizumab prophylaxis of RSV infections in Bosnia and Herzegovina

Background: Palivizumab is indicated for respiratory syncytial virus (RSV) prophylaxis in high-risk children. Methods: Observational study, based on 4 sites in Bosnia and Herzegovina (B&H), with institutional reports of infants at high risk for RSV who received at least 1 dose of palivizumab...

Full description

Bibliographic Details
Main Authors: Suada Heljic, Hajrija Maksic, Hidajeta Begic, Fahrija Skokic, Darinka Glamuzina, Tomica Bozic, Stojislav Konjevic, Veroslava Milosevic, Sabina Terzic
Format: Article
Language:English
Published: Hygeia Press di Corridori Marinella 2016-02-01
Series:Journal of Pediatric and Neonatal Individualized Medicine
Subjects:
palivizumab
rsv prophylaxis
preterm infants
bpd/cld
chd
Online Access:https://www.jpnim.com/index.php/jpnim/article/view/346

Internet

https://www.jpnim.com/index.php/jpnim/article/view/346

Similar Items